stars 1 stars 2 stars 3

Harmony Biosciences is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare and other neurological diseases with unmet medical needs. Guided by empathy, driven by science, and focused on innovation, we combine a strong commercial foundation with a growing pipeline of differentiated programs designed to advance treatment across multiple neurological conditions. By creating long-term value through scientific innovation, operational excellence, and disciplined execution, we invest in our people, our pipeline, and our mission to help improve patients’ lives. Follow us: Instagram → @harmony_biosciences X → @harmonybio #InHarmony #EmpathyAndInnovation View community guidelines: http://bit.ly/4v2Exc8

Harmony Biosciences Questions

The Harmony Biosciences annual revenue was $681.9 million in 2026.

Jeffrey Dayno is the President and Chief Executive Officer of Harmony Biosciences.

279 people are employed at Harmony Biosciences.

Harmony Biosciences is based in Plymouth Meeting, Pennsylvania.

The NAICS codes for Harmony Biosciences are [32541, 54, 32, 3254, 325, 541].

The SIC codes for Harmony Biosciences are [87, 873, 28, 283].

Top Harmony Biosciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users